PI
-
The effect of empagliflozin on peripheral microvascular dysfunction in patients with heart failure with preserved ejection fraction
Mourmans, S. G. J., Achten, A., Hermans, R., Scheepers, M. J. E., D’Alessandro, E., Swennen, G., Woudstra, J., Appelman, Y., Goor, H. V., Schalkwijk, C., Knackstedt, C., Weerts, J., Eringa, E. C. & van Empel, V. P. M., 1 Dec 2025, In: Cardiovascular Diabetology. 24, 1, 182.Research output: Contribution to journal › Article › Academic › peer-review
-
Empagliflozin prevents myocardial immune infiltration in uraemic mice exposed to peritoneal dialysis fluids.
Kane, J. A., Karsten, M., van Bergen, A. S., Lutgens, E., van den Brom, C. E., Vervloet, M., Eringa, E. C. & L, J., 10 Aug 2025, (In preparation) In: Journal of the American Heart Association.Research output: Contribution to journal › Article › Academic › peer-review
-
The role of epicardial adipose tissue remodelling in heart failure with preserved ejection fraction
Janssen-Telders, C., Eringa, E. C., de Groot, J. R., de Man, F. S. & Handoko, M. L., 1 May 2025, In: Cardiovascular Research. 121, 6, p. 860-870 11 p.Research output: Contribution to journal › Review article › Academic › peer-review
- All publications